175 related articles for article (PubMed ID: 24015031)
1. Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea.
Choe YJ; Yang JJ; Park SK; Choi EH; Lee HJ
J Korean Med Sci; 2013 Sep; 28(9):1283-8. PubMed ID: 24015031
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with recommendation behaviors of four non-National Immunization Program vaccines: a cross-sectional survey among public health workers in China.
Lyu Y; Lai X; Ma Y; Fang H
Infect Dis Poverty; 2023 Oct; 12(1):91. PubMed ID: 37805654
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of immunization coverage of migrant children between national immunization program vaccines and non-national immunization program vaccines in East China.
Hu Y; Luo S; Tang X; Lou L; Chen Y; Guo J
Hum Vaccin Immunother; 2015; 11(3):761-8. PubMed ID: 25760670
[TBL] [Abstract][Full Text] [Related]
4. Coverage and Equity of Childhood Vaccines in China.
Zhang H; Lai X; Mak J; Sriudomporn S; Zhang H; Fang H; Patenaude B
JAMA Netw Open; 2022 Dec; 5(12):e2246005. PubMed ID: 36484985
[TBL] [Abstract][Full Text] [Related]
5. The coverage and challenges of increasing uptake of non-National Immunization Program vaccines in China: a scoping review.
Jiang M; Chen S; Yan X; Ying X; Tang S
Infect Dis Poverty; 2023 Dec; 12(1):114. PubMed ID: 38062480
[TBL] [Abstract][Full Text] [Related]
6. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
Constenla D; Liu T
Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
[TBL] [Abstract][Full Text] [Related]
7. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
[TBL] [Abstract][Full Text] [Related]
8. Immunization coverage, knowledge, satisfaction, and associated factors of non-National Immunization Program vaccines among migrant and left-behind families in China: evidence from Zhejiang and Henan provinces.
Zhou Y; Li D; Cao Y; Lai F; Wang Y; Long Q; Zhang Z; An C; Xu X
Infect Dis Poverty; 2023 Oct; 12(1):93. PubMed ID: 37833775
[TBL] [Abstract][Full Text] [Related]
9. Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.
Chen S; Rodewald LE; Du AH; Tang S
Infect Dis Poverty; 2024 Mar; 13(1):25. PubMed ID: 38475849
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
[TBL] [Abstract][Full Text] [Related]
11. Predictors of uptake of newly introduced vaccines in Malawi - monovalent human rotavirus and pneumococcal conjugate vaccines: Evidence from the 2015-16 Malawi demographic and health survey.
Ntenda PAM; Mwenyenkulu ET; Putthanachote N; Nkoka O; Mhone TG; Motsa MPS; Tizifa T
J Trop Pediatr; 2019 Jun; 65(3):287-296. PubMed ID: 30085260
[TBL] [Abstract][Full Text] [Related]
12. The impact of rotavirus vaccination on acute diarrhea in Thai children under 5 years of age in the first year of universal implementation of rotavirus vaccines in the National Immunization Program (NIP) in Thailand: a 6-year analysis.
Charoenwat B; Suwannaying K; Paibool W; Laoaroon N; Sutra S; Thepsuthammarat K; Sirirattanakul S
BMC Public Health; 2023 Oct; 23(1):2109. PubMed ID: 37891542
[TBL] [Abstract][Full Text] [Related]
13. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
De Waure C; Sisti LG; Poscia A; Ricciardi W
Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
[TBL] [Abstract][Full Text] [Related]
14. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
[TBL] [Abstract][Full Text] [Related]
15. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
Trucchi C; Zoppi G
J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
[TBL] [Abstract][Full Text] [Related]
16. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
17. Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's National Immunization Program.
Flannery B; Samad S; de Moraes JC; Tate JE; Danovaro-Holliday MC; de Oliveira LH; Rainey JJ
Vaccine; 2013 Mar; 31(11):1523-8. PubMed ID: 23313652
[TBL] [Abstract][Full Text] [Related]
18. Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea.
Choe YJ; Han OP; Cho H; Bae GR; Chun BC; Kim JH; Kim KH; Lee HJ; Choi EH
Vaccine; 2014 Oct; 32(46):6049-53. PubMed ID: 25239482
[TBL] [Abstract][Full Text] [Related]
19. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
Zoppi G; Trucchi C
J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
[TBL] [Abstract][Full Text] [Related]
20. Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.
Rosenthal J; Rodewald L; McCauley M; Berman S; Irigoyen M; Sawyer M; Yusuf H; Davis R; Kalton G
Pediatrics; 2004 Apr; 113(4):e296-302. PubMed ID: 15060256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
